Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions


Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

PBAC Decision to Approve Biosimilars for Pharmacy Substitution is a Safety Concern for Patients

Medicines Australia notes with concern the recommendation by the Pharmaceutical Benefits Advisory Committee (PBAC) that pharmacists be allowed to substitute biosimilars in place of biologic medicines prescribed by a patient’s doctor. The so-called “a-flagging” means that pharmacists can make this substitution without the knowledge or consent of the patient’s specialist doctor, GP or even the…

View article· Friday, 21 August 2015

Australian Medicine exports drop by 30 per cent in one year

The continuing decline in Australian exports of medicines has highlighted the enormous challenges facing the local industry as they struggle to remain competitive in the global pharmaceutical industry. Just five years ago, medicines were Australia’s largest manufactured export, bringing in more than $4 billion to the local economy. Today, manufactured medicines have slipped to second…

View article· Friday, 7 August 2015

New Facts Book shows more than 900 biologic medicines and vaccines in development

An informative source of key statistics and trends in the Australian and International medicines industry has today been published in the latest edition of the Medicines Australia Facts Book (4th Edition). The findings show that the global market for medicines and vaccines is set to double over the next decade, with much of the growth…

View article· Friday, 24 July 2015

Medicines Australia Provides Additional Submission to Senate Inquiry on Corporate Global Tax Issues

Australia’s innovative medicines industry body has provided a supplementary submission to the Senate Inquiry into Corporate Tax Avoidance addressing several issues raised at the public hearing in Sydney this month. Global tax arrangements such as transfer pricing are complex measures which are easily misunderstood. This can unfortunately lead to confusion within the community and erode…

View article· Thursday, 23 July 2015

Medical Research Future Fund will improve Australia’s competitiveness in world class innovation

Medicines Australia has tabled a submission urging the Parliament to pass legislation that will create the Medical Research Future Fund (MRFF). However, if the MRFF is to succeed in addressing the health needs of the future it needs close collaboration with Australia’s innovative medicines industry. The MRFF can be a positive step forward for Australia,…

View article· Monday, 13 July 2015

Stop the fearmongering: free trade and a globally competitive intellectual property system will benefit Australia

Medicines Australia remains concerned by the increasingly alarmist and misguided reporting by sections of the media on negotiations for the Trans Pacific Partnership (TPP) and its impacts on the prices for medicines in Australia. “The same fearmongering about price rises for medicines and the collapse of the Pharmaceutical Benefits Scheme (PBS) happened a decade ago…

View article· Thursday, 9 July 2015

Delivering commercial success from University research must involve the innovative research-based medicines industry

Medicines Australia welcomes the Federal Government review of University research funding and policy which aims to find more ways to turn the hard work of Australian scientists into commercial success. Medicines Australia CEO Tim James said, “Australia’s Universities have a great reputation for research and development around the world but they have often found it…

View article· Wednesday, 8 July 2015

Medicines Australia boosts Transparency measures in Code of Conduct

An awareness campaign has been launched by Medicines Australia to ensure healthcare professionals are aware of and understand the effects of new transparency enhancements contained in our updated Code of Conduct. From 1 October 2015, Medicines Australia 18th Edition of its Industry Code of Conduct will require payments to healthcare professionals to be disclosed online…

View article· Monday, 6 July 2015

Health Industry Forum outlines opportunities for investment and growth in Australia’s innovative medicines sector

Medicines Australia was pleased to attend the first Health Industry Forum, hosted by Industry Minister Ian Macfarlane MP, Health Minister Sussan Ley MP and Assistant Health Minister Fiona Nash MP at Parliament House today. The forum provided an opportunity for government and industry to work together to highlight opportunities for future investment and growth in…

View article· Thursday, 25 June 2015

Independent review of TGA provides sensible solutions to accelerate access to new Medicines

Medicines Australia welcomes the recommendations of an independent review into the Therapeutic Goods Administration (TGA) which, if adopted, will help to cut time delays and improve Australian’s access to new, innovative medicines. The Review examined the TGA’s regulatory framework and processes with a view to identifying areas of unnecessary red tape and opportunities to enhance…

View article· Thursday, 25 June 2015

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


AUS faces stiff competition for investment in medicines manufacturing. Other countries are fighting hard for investment $$ #health #auspol

Meds & vaccines one of Aust. biggest manufactured exports. Global market for these products is set to double over nxt decade #health #auspol

$350k for better indigenous access to + awareness of #cancer care services @sussanley #health #auspol

On average, it takes an estimated 22 months to get a new PBS medicine listed #auspol #health

The Parkinson's @UnityWalkRun has raised over $900,000 for people living with the disease – support the #unitywalk at

Medicines industry has worked with successive AUS govts to ensure the sustainability of the PBS #health #auspol

Each day 350 Aussies are diagnosed with cancer. #DaffodilDay funds mean more research discovery & new treatments

AUS has some of highest immunisation rates against infectious diseases globally but rates have slid #health #auspol

Did you know: the average life expectancy for AUS women is 84.2 years, seventh highest in the world #auspol #health

RT @HCNSW: At launch of Working Together Guide roadmap between #HealthConsumers and #pharmaceutical companies @CHFofAustralia @MedicinesAus